NextCure, Inc. - Common Stock (NXTC)

Gainers NextCure (NASDAQ:NXTC) stock increased by 201.4% to $6.57 during Tuesday's regular session. The market value of their outstanding shares is at $7.8 million. Shuttle Pharmaceuticals (NASDAQ:SHPH) shares

Gainers NextCure (NASDAQ:NXTC) shares rose 305.5% to $8.84 during Tuesday's pre-market session. The market value of their outstanding shares is at $7.8 million. Shuttle Pharmaceuticals (NASDAQ:SHPH) stock moved

U.S. stock futures swung between gains and losses on Friday after ending on a mixed note on Thursday. Futures were mixed.

NC605 boosted bone density and quality, including improved cortical thickness and reduced bone fragility.

NextCure Inc. (NASDAQ: NXTC) surged by 44.87% in after-hours trading on Thursday, following presentation of new preclinical data for NC605.

After the closing bell on Thursday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.

Curious to know what's happening on the US markets one hour before the close of the markets on Monday? Join us as we explore the top gainers and losers in today's session.

The newly announced partnership aims to develop SIM0505, a novel antibody-drug conjugate developed by Simcere Zaiming for the treatment of solid tumors.

Discover the top movers in Thursday's pre-market session and stay informed about market dynamics.

NXTC stock results show that NextCure missed analyst estimates for earnings per share the second quarter of 2024.

NXTC stock results show that NextCure missed analyst estimates for earnings per share the first quarter of 2024.

The market is surging higher after dovish Fed comments. Here are seven of Wall Street’s favorite penny stocks that can help make you rich